跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARX-DABIGATRAN dabigatran etexilate (as mesilate) 110 mg capsule blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ARX-DABIGATRAN dabigatran etexilate (as mesilate) 110 mg capsule blister pack
Approved
STANDARD
ARX-DABIGATRAN dabigatran etexilate (as mesilate) 110 mg capsule blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
8a0cb819ee08468c
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
8a0cb819ee08468c
Product Name
ARX-DABIGATRAN dabigatran etexilate (as mesilate) 110 mg capsule blister pack
Artg Id
414771
Artg Name
ARX-DABIGATRAN dabigatran etexilate (as mesilate) 110 mg capsule blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2023-10-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/0edd520f074035be737f71b9026db05e.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/7170a569764d92edf145eac54045aae0.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
8a0cb819ee08468c
Type
Standard
Back to TGA Approvals